Dr. Pawel Kalinski, MD, Ph.D. is a Senior Vice President at Roswell Park Comprehensive Cancer Center and a Chairman of the Department of Immunology of Roswell. His research interests involve immunology and immunotherapy of cancer and infectious diseases, bioengineering, cancer vaccines, dendritic cells, T cells, NK cells, cytokines, chemokines, prostanoids and interferons. He has authored more than 150 publications in international peer-reviewed journals and developed multiple INDs and early phase clinical trials of cancer and infections.